Abstract
The central function of the mesangial cell within the kidney is the control of glomerular filtration rate primarily via the regulation of mesangial cell tone. A secondary function of this specialised pericyte is to maintain the integrity of the glomerulus via matrix synthesis and provide support for the capillary loops. The elicitation of neutrophils and monocytes from the circulation into the inflamed glomerulus accompanied by proliferation of resident mesangial cells and expansion of mesangial matrix are prominent features of immunologically mediated glomerulonephritis (1).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Couser, W. G. 1990. Mediation of immune glomerular injury. J. Am. Soc. Nephrol.1: 13–29.
Chemotactic cytokines: biology of the inflammatory peptide supergene family. 1991, Advances in Experimental Medicine and Biology. Eds. J Westwick, I.J.D Lindley and S.L Kunkel, Plenum, New York.
Westwick, J., S.W. Li, and R.D. Camp. 1989. Novel neutrophil-stimulating peptides. Immunol. Today.10:146–147.
Leonard, E.J., and T. Yoshimura. 1990. Human monocyte chemoattractant protein-1. Immunol. Today.11:97–101.
Mene, P., M.S. Simonson, and M.J. Dunn. 1989. Physiology of the mesangial cell. Physiol Rev. 69: 1347–1424.
Sedor, J.R., Y. Nakazato, and M. Konieczkowski. 1992. Interleukin-I and the mesangial cell. Kidney International. 41: 595–599.
Brown, Z., R.M. Strieter, S.W. Chensue, M. Ceska, I. Lindley, G.H. Neild, S.L. Kunkel, and J. Westwick. 1991. Cytokine activated human mesangial cells generate the neutrophil chemoattractantinterleukin 8. Kidney Int. 40: 86–90.
Kunser, D.J., E.L. Luebbers, R.J. Nowinski, M. Konieczkowski, C.H. King, and J.R. Sedor, 1991. Cytokine and LPS-induced synthesis of interleukin-8 from human mesangial cells. Kidney Int. 39: 1240–1248.
Zoja, C., J.M. Wang, S. Bettoni, M. Sironi, D. Renzi, F. Chiaffarino, H.E. Abboud, J. Van Damme,A. Mantovani, G. Remuzzi, and A. Rambaldi. 1991. Interleukinβ and TNFα induce gene expression and production of leukocyte chemotactic factors, colony-stimulating factors and interleukin-6 in human mesangial cells. Am. J. Pathol. 138:991–1003.
Abbott, F., J.J. Ryan, M. Ceska, K. Matsushima, C.E. Sarraf, and A.J. Rees. 1991. Interleukin-lß stimulates human mesangial cells to synthesize and release interleukin-6 and -8. Kidney Int. 40: 597605.
Brown, Z., L. Fairbanks, R.M. Strieter, G.H. Neild, S.L. Kunkel, and J. Westwick. 1991. Human mesangial cell-derived IL-8 and IL-6: modulation by an interleukin 1 receptor antagonist. in Chemotactic cytokines: biology of the inflammatory peptide supergene family. Advances in Experimental Medicine and Biology, 305: 119–126. Eds. J Westwick, I.J.D Lindley and S.L.Kunkel, Plenum, New York.
Brown, Z., R.M. Strieter, G.H. Neild, R.C. Thompson, S.L. Kunkel, and J. Westwick. 1992. IL-1 receptor antagonist inhibits monocyte chemotactic peptide 1 generation by human mesangial cells. Kidney Int. 42: 95–101.
Moncada, S., R.M.J. Palmer, and E.A. Higgs. 1991. Nitric oxide: physiology, pathophysiology and parmacology. Pharma. Rev.43: 109–142.
Cairns, H.S., M.E. Rogerson, J. Westwick, and G.H. Neild. 1991. Regional heterogeneity of endothelium-dependent vasodilatation in the rabbit kidney. J. Physiol.436: 421–429.
Palmer, R.M.J., D.S. Ashton, and S. Moncada. 1988. Vascular endothelial cells synthesise nitric oxide from L-arginine. Nature. 333: 664 - 666.
Rapoport, R.M., and F. Murad. 1988. Role of cyclic GMP in endothelium-dependent relaxation of vascular smooth muscle. In Relaxing and Contracting Factors. P.M. Vanhoutte, editor. Humana press, Clifton, NJ. 219–239.
Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB. J.6: 3051–3064.
Schmidt, H.H.H.W., and F. Murad. 1991. Purification and characterization of a human NO synthase. Biochem. Biophys. Res. Commun.181: 1372–1377.
Bredt, D.S. and S.H. Snyder. 1990. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA87: 682–685.
Stuehr, D., N. Kwon, and C. Nathan. 1990. FAD and GSH participate in macrophage synthesis of nitric oxide. Biochem. Biophys. Res. Commun.168: 558–565.
Yui, Y., R. Hattori, K. Kosuga, H. Eizawa, K. Hiki, S. Ohkawa, K. Ohnishi, S. Terao, and C. Kawai. 1991. Calmodulin-independent nitric oxide synthase from rat polymorphonuclear neutrophils. J. Biol. Chem.266: 3369–3371.
Radomski, M.W., R.M.J. Palmer, and S. Moncade. 1990. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. USA87: 10043–10047.
Knowles, R.G., M. Salter, S.L. Brooks, and S. Moncada. 1990. Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat. Biochem. Biophys. Res. Commun.172: 1042–1048.
Shultz, P.J., J.R. Sedor, and H.E. Abboud. 1990. Effects of endothelium-derived relaxing factor and nitric oxide on rat mesangial cells. Am. J. Physiol.258 (Renal Fluid Electrolyte Physio1.27): F162–F167.
Shultz, P.J., M.A. Tayeh, M.A. Marietta, and L. Raij. 1991. Synthesis and action of nitric oxide in rat glomerular mesangial cells. Am. J. Physiol.261 (Renal Fluid Electrolyte Physiol. 30): F600–606.
Pfeilschifter, J., P. Rob, A. Mulsch, J. Fandrey, K. Vosbeck, and R. Busse. 1992. Interleukin Iß and tumour necrosis factor induce a macrophage-type of nitric oxide synthase in rat renal mesangial cells. Eur.J. Biochem.203: 251–255.
Pfeilschifter, J., and H. Schwarzenbach. 1990. Interleukin 1 and tumor necrosis factor stimulate cGMP formation in rat renal mesangial cells. Febs Lett. 273: 185.
Pfeilschifter, J. 1991. Anti-inflammatory steroids inhibit cytokine induction of nitric oxide synthase in rat renal mesangial cells. Eur. J. Pharmacol.195: 179–180.
McCall, T.B., N.K. Boughton-Smith, R.M.J. Palmer, B.J.R. Whittle, and S. Moncada. 1989. Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion. Biochem. J.261: 293–296.
Martin, W., G.M. Villani, D. Jothianandan, and R.F. Furchgott. 1985. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharm. Exp. Therap.232: 708–716.
Schmidt, M.J., B.D. Sawyer, L.L. Truex, W.S. Marshall, and J.H. Fleisch. 1985. LY83583: An agent that lowers intracellular levels of cyclic guanosine 3’,5’-monophosphate. J Pharm. Exp. Therap.232: 764–769.
Mulsch, A., R. Busse, S. Liebau, and U. Forstermann. 1988. LY83583 interferes with the release of endothelium-derived relaxing factor and inhibits soluble guanylate cyclase. J. Pharm. Exp. Therap.247: 283–288.
Katsuki, S., W. Arnold, C. Mittal, and F. Murad. 1977. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J. Cyclic Nucl. Res.3: 23–55.
Rees, D.D., R.M.J. Palmer, R. Schulz, H.H. Hodson, and S. Moncada. 1990. Characterization of three inhibitors of endothelial nitric oxide synthase in vitroand in vivo. Br. J. Pharmacol.101: 746–752.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Brown, Z., Robson, R.L., Westwick, J. (1993). L-Arginine/Nitric Oxide Pathway: A Possible Signal Transduction Mechanism for the Regulation of the Chemokine IL-8 in Human Mesangial Cells. In: Lindley, I.J.D., Westwick, J., Kunkel, S. (eds) The Chemokines. Advances in Experimental Medicine and Biology, vol 351. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2952-1_8
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2952-1_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6283-8
Online ISBN: 978-1-4615-2952-1
eBook Packages: Springer Book Archive